Tag Archives: Tel Aviv University

Innocan Pharma announced the successful completion of a large-scale production of exosomes. Innocan’s CBD Loaded Exosome (CLX) Therapy project led by Prof. Offen demonstrates the capability of having reliable large-scale production of exosomes and is an important milestone in the ...

InnoCan Pharma announced that its wholly-owned subsidiary, InnoCan Pharma Ltd. of Herzliya Israel, has entered into a sponsored research agreement with Ramot at Tel Aviv University to collaborate with Tel Aviv university to develop a novel, revolutionary...

Stem Cell Medicine Ltd. (SCM), a biotechnology company developing new therapies for neurological indications, including mesenchymal stem cells and anti-BMP molecules for the treatment of Multiple...

Autism spectrum disorders (ASD) are neurodevelopmental disorders characterized by three core symptoms that include social interaction deficits, cognitive inflexibility, and communication disorders...

Oral cancer (OC) patients are at high risk to develop recurrent disease or secondary primary cancers with no available biomarkers to detect these events until a visible lesion is readily present and diagnosed by biopsy. Exosomes secreted by cancer cells ...

TAU researcher advances novel strategy to fight cancer by shoring up the immune system Two years ago, Prof. Eshel Ben-Jacob of Tel Aviv University‘s School of Physics and Astronomy and Rice University’s Center for Theoretical Biological Physics made the startling ...